Literature DB >> 7945281

Galactosyl and N-acetylgalactosaminyl homeostasis: a function for mammalian asialoglycoprotein receptors.

P H Weigel1.   

Abstract

Mammalian livers express endocytic cell surface receptors that specifically bind natural or synthetic molecules containing terminal galactosyl or N-acetylgalactosaminyl sugars. One of these hepatocyte receptors is the asialoglycoprotein receptor, which mediates the endocytosis and subsequent lysosomal degradation of these glyco-molecules. Although the receptor was discovered almost 30 years ago, the physiological reason why mammals have this receptor is still unknown. At the cellular level, the basic molecular function of the receptor is to mediate the uptake and ultimate degradation of galactosyl/N-acetylgalactosaminyl-containing molecules (ligands). At the organism level, however, the physiological function is uncertain. The identity of the natural ligands and the reasons for this elaborate receptor system to remove these ligands are both unknown. This article proposes an explanation for the purpose of this asialoglycoprotein receptor and its role in regulating the dynamic flux of galactosyl/N-acetylgalactosaminyl glycoconjugates in mammals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945281     DOI: 10.1002/bies.950160713

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  22 in total

1.  Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells.

Authors:  D L Jarvis; D Howe; J J Aumiller
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.

Authors:  Jared J Aumiller; Jason R Hollister; Donald L Jarvis
Journal:  Glycobiology       Date:  2003-02-20       Impact factor: 4.313

3.  Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins.

Authors:  S André; B Frisch; H Kaltner; D L Desouza; F Schuber; H J Gabius
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

4.  Establishment of a functional cell line expressing both subunits of H1a and H2c of human hepatocyte surface molecule ASGPR.

Authors:  Bin Hu; Yan Yang; Jia Liu; Zhiyong Ma; Hongping Huang; Shenpei Liu; Yuan Yu; Youhua Hao; Baoju Wang; Mengji Lu; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

5.  Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans.

Authors:  Jason Hollister; Eckart Grabenhorst; Manfred Nimtz; Harald Conradt; Donald L Jarvis
Journal:  Biochemistry       Date:  2002-12-17       Impact factor: 3.162

6.  Capacity limits of asialoglycoprotein receptor-mediated liver targeting.

Authors:  Charlotte Bon; Thomas Hofer; Alain Bousquet-Mélou; Mark R Davies; Ben-Fillippo Krippendorff
Journal:  MAbs       Date:  2017-09-06       Impact factor: 5.857

7.  A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes.

Authors:  Jia Liu; Bin Hu; Yan Yang; Zhiyong Ma; Yuan Yu; Shenpei Liu; Baoju Wang; Xiping Zhao; Mengji Lu; Dongliang Yang
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

8.  Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands.

Authors:  Lesley G Ellies; David Ditto; Gallia G Levy; Mark Wahrenbrock; David Ginsburg; Ajit Varki; Dzung T Le; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

9.  The Ashwell receptor mitigates the lethal coagulopathy of sepsis.

Authors:  Prabhjit K Grewal; Satoshi Uchiyama; David Ditto; Nissi Varki; Dzung T Le; Victor Nizet; Jamey D Marth
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

10.  Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology.

Authors:  Pieter P Jacobs; Steven Geysens; Wouter Vervecken; Roland Contreras; Nico Callewaert
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.